To investigate whether BNIP3 mediated FTO-dependent tumor growth and progression, we generated two distinct shRNAs targeting BNIP3 (shBNIP3–1 and shBNIP3–2) in FTO stable knockdown breast cancer cells (Additional file 8: Figure S5A-C). This evidence concerns the gene BNIP3 and neoplasm.